hematogenix.com
HomeAt Your Fingertips Today! Hematogenix is the market leader in immuno-oncology testing with the addition of PD-L1 Read more.
http://www.hematogenix.com/
At Your Fingertips Today! Hematogenix is the market leader in immuno-oncology testing with the addition of PD-L1 Read more.
http://www.hematogenix.com/
TODAY'S RATING
#545,168
Date Range
HIGHEST TRAFFIC ON
Sunday
LOAD TIME
1 seconds
16x16
32x32
Domains By Proxy, LLC
Registration Private
Domain●●●●●●xy.com
14747 N Norths●●●●●●●●●●●●●●e 111, PMB 309
Sco●●●ale , Arizona, 85260
United States
View this contact
Domains By Proxy, LLC
Registration Private
Domain●●●●●●xy.com
14747 N Norths●●●●●●●●●●●●●●e 111, PMB 309
Sco●●●ale , Arizona, 85260
United States
View this contact
Domains By Proxy, LLC
Registration Private
Domain●●●●●●xy.com
14747 N Norths●●●●●●●●●●●●●●e 111, PMB 309
Sco●●●ale , Arizona, 85260
United States
View this contact
BUY YOUR DOMAIN
18
YEARS
1
MONTHS
11
DAYS
GODADDY.COM, LLC
WHOIS : whois.godaddy.com
REFERRED : http://registrar.godaddy.com
PAGES IN
THIS WEBSITE
0
SSL
EXTERNAL LINKS
4
SITE IP
109.73.224.17
LOAD TIME
1.045 sec
SCORE
6.2
Home | hematogenix.com Reviews
https://hematogenix.com
At Your Fingertips Today! Hematogenix is the market leader in immuno-oncology testing with the addition of PD-L1 Read more.
Home
Sunday, August 16, 2015, 05:25 PM. Click here for Hematogenix Pharma. Histology and In Situ Hybridization. Comprehensive Molecular Profiling Test - iDNAfy. THxID BRAF Press Release. RNAscope -ISH Press Release. Histology and In Situ Hybridization. Test Offering Quick Sheet. Physicians and their authorized staff receive secure access to their own space in Hematopass allowing them to monitor case progress in real time and download patient reports directly once it become available.
Hematogenix Pharma Services
Click Here for Hematogenix Diagnostics. Biomarker & Assay Development. ANATOMIC and MOLECULAR PATHOLOGY. Molecular technologies within the context of morphology provide the complete picture. SOLID TISSUE and HEMATOLOGIC SPECIMENS. We offer the people, platforms and storage to test and manage both types of specimens. RESEARCH and REFERENCE TESTING. Biomarker & Assay Development.
About Us | Hematogenix Pharma Services
http://www.pharma.hematogenix.com/about
Click Here for Hematogenix Diagnostics. Biomarker & Assay Development. We are a CAP, CLIA-certified laboratory that is designed to meet your regulatory, clinical and research requirements. A full complement of board-certified clinical, anatomic and research pathologists provide consultation and guidance for each project. The research and clinical trials services of our Pharma Services Division are further amplified by its parent company, Hematogenix Laboratory Services ( www.hematogenix.com. The challeng...
RNAscope® ISH Assays Press Release | Hematogenix Pharma Services
http://www.pharma.hematogenix.com/rnascope-ish-assays-press-release
Click Here for Hematogenix Diagnostics. Biomarker & Assay Development. Hematogenix Laboratory Services LLC – The First Diagnostic Testing and CLIA-Certified Biomarker Services Laboratory to Offer Advanced Cell Diagnostics, RNAscope Assays to Clients. About Advanced Cell Diagnostics, Inc. Biomarker & Assay Development.
TOTAL LINKS TO THIS WEBSITE
4
Strona w przygotowaniu...
Opcje dostępne dla administratora, bądź uprawnionego użytkownika usługi:. Strona utrzymywana na serwerach hom e.
www.hematogenas.com - Baltnetos komunikacijos
IP: 217.117.28.78. UAB "Baltnetos komunikacijos" teikia visas hostingo bei duomenų centro paslaugas:. Virtualus dedikuotas serveris;. Tel: 8 5 274 5444 / pagalba internetu.
Titulinis | HEMATOGENAS
Hematogeno akcija BENU vaistinėse. Hematogeno akcija Camelia vaistinėse. Hematogeno akcija IKI parduotuvėse. 2013-2015 Sprendimas: VRS WPI Vilnius.
www.hematogenas.net - Baltnetos komunikacijos
IP: 217.117.28.78. UAB "Baltnetos komunikacijos" teikia visas hostingo bei duomenų centro paslaugas:. Virtualus dedikuotas serveris;. Tel: 8 5 274 5444 / pagalba internetu.
hematogene.com
Inquire about this domain. The Sponsored Listings displayed above are served automatically by a third party. Neither the service provider nor the domain owner maintain any relationship with the advertisers. In case of trademark issues please contact the domain owner directly (contact information can be found in whois).
Home
At Your Fingertips Today! Hematogenix is the market leader in immuno-oncology testing with the addition of PD-L1 Read more.
Hematogones.com - Online Pathology / Laboratory tools
Placenta Weights and Reports. Kleihauer-Betke RhIg Dosing tool. Snippets / Macros Locker. Full List of Synoptics. Appendix, Neuroendocrine tumors. Bone Tumors, biopsy or resection. CNS Tumors, biomarker. Ewing Sarcoma/PNET, biopsy or resection. Extra-gonadal germ cell tumors. Pediatric Kidney (Wilms) Tumor. Soft Tissue Tumors, resection. Appendix, Neuroendocrine tumors. Breast Cancer, DCIS. Breast Cancer, Invasive. Bone tumors, biopsy or resection. Cervical cancer - Leep/Cone. CNS tumors, biomarker.
hematoinfo.com
This page is parked free, courtesy of Google Inc. Use of this Site is subject to express Terms of Use. By using this Site, you signify that you agree to be bound by these Terms of Use. Which were last revised on.
IIS7
اینده ایران را چگونه می بینید؟
اینده ایران را چگونه می بینید؟ اینده ایران را چگونه می بینید؟ به گزارش ایسنا، سایت هریتیج کی در گزارشی به معرفی پنج شهر تاریخی در خطر جهان در عراق، کامبوج، پرو، اردن و ترکیه پرداخته که عبارتند از:. 1 شهر تاریخی بابل در عراق:. شهر تاریخی بابل با چندهزار سال قدمت در دهههای اخیر، شرایط متفاوتی را تجربه کرده است. در سالهای نخستین حکومت دیکتاتور عراق، صدام، این شهر بهشکل کامل مرمت و به یکی از قطبهای گردشگری عراق تبدیل شد و حتا صدام یکی از کاخهای خود را بر فراز تپهای در نزدیکی این شهر بنا کرد. شهر تاریخی بابل ...
top | 血液・腫瘍内科 | 東海大学医学部内科学系
教授 2名 准教授 2名 講師 3名 助教 6名 大学院 2名. 東海大学医学部付属八王子病院 教授1名、 講師1名、 助手1名. 海老名総合病院 講師1名、助教2名 、小澤病院 助教3名. 秦野赤十字病院 准教授1名、助教1名、臨床助手1名 、厚木佐藤病院 助教3名. 伊勢原協同病院 講師1名、助教3名 、国立がん研究センター 助教1名. 認定医 専門医、指導医の数 出向先 関連病院等も含めた合計. 過去5 年間に発表した主なpeer review journal. 当科は、日本の臨床腫瘍学、白血病の治療 研究の中心を担っているJapan Clinical Oncology Group (JCOG)、Japan Adult Leukemia Study Group (JALSG) に所属し、その他にも多施設共同の臨床試験に参加しております。 単に臨床試験に参加するのみでなく、JCOG で現在行われている第3 相試験の事務局を担い、また、JALSG のプロトコール検討委員会にも加わっており、日本の白血病 悪性リンパ腫診療のエビデンス創造に深く関わっております。
